[HTML][HTML] Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients

N Tay, EL Laakso, D Schweitzer, R Endersby… - Frontiers in molecular …, 2022 - frontiersin.org
Brain cancer and leukemia are the most common cancers diagnosed in the pediatric
population and are often treated with lifesaving chemotherapy. However, chemotherapy …

[HTML][HTML] Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with …

R Brownson-Smith, ST Orange, N Cresti, K Hunt… - Journal of Cancer …, 2023 - Springer
Purpose To systematically review and meta-analyse the efficacy of exercise interventions
delivered before and/or during taxane-containing chemotherapy regimens on chemotherapy …

Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy among patients treated for Ovarian Cancer: a secondary analysis of a Randomized Clinical Trial

A Cao, B Cartmel, FY Li, LT Gottlieb… - JAMA network …, 2023 - jamanetwork.com
Importance Chemotherapy-induced peripheral neuropathy (CIPN), one of the most common
and severe adverse effects of chemotherapy, is associated with worse quality of life among …

[HTML][HTML] Mechanisms of exercise in the treatment of lung cancer–a mini-review

Z Luo, R Wan, S Liu, X Feng, Z Peng, Q Wang… - Frontiers in …, 2023 - frontiersin.org
Lung cancer constitutes a formidable menace to global health and well-being, as its
incidence and mortality rate escalate at an alarming pace. In recent years, research has …

Preliminary evaluation of novel Bodily Attention Task to assess the role of the brain in chemotherapy-induced peripheral neurotoxicity (CIPN)

T Manuweera, A Wagenknecht, AS Kleckner… - Behavioural Brain …, 2024 - Elsevier
Chemotherapy-induced peripheral neurotoxicity (CIPN) is a common, sometimes dose-
limiting side effect of neurotoxic chemotherapy. Treatment is limited because its …

Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN)

S Stoller, S Capozza, P Alberti, M Lustberg… - Supportive Care in …, 2023 - Springer
Purpose Chemotherapy-induced peripheral neurotoxicity (CIPN) is a highly prevalent, dose-
limiting, costly, and tough-to-treat adverse effect of several chemotherapy agents, presenting …

Recent advances in managing chemotherapy-induced peripheral neuropathy: A systematic review

M Wang, Z Pei, A Molassiotis - European Journal of Oncology Nursing, 2022 - Elsevier
Purpose The aim in this review was to explore recent advances in chemotherapy-induced
peripheral neuropathy (CIPN) management interventions and to identify the implications for …

[HTML][HTML] Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study

S Lixian, Y Xiaoqian, G Luyan, Z Lizhi, D Rui… - Frontiers in …, 2024 - frontiersin.org
Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a common and severe
adverse reaction in taxane-based chemotherapy. This study aimed to analyze the risk …

[HTML][HTML] Non-pharmacological self-management strategies for chemotherapy-induced peripheral neuropathy in people with advanced cancer: a systematic review and …

M Crichton, PM Yates, OA Agbejule, A Spooner… - Nutrients, 2022 - mdpi.com
Non-pharmacological self-management interventions for chemotherapy-induced peripheral
neurotherapy (CIPN) are of clinical interest; however, no systematic review has synthesized …

Towards a mechanistic understanding of axon transport and endocytic changes underlying paclitaxel-induced peripheral neuropathy

GJ Shin - Experimental Neurology, 2023 - Elsevier
Paclitaxel is a common chemotherapeutic agent widely used to treat solid cancer. However,
it frequently causes peripheral sensory neuropathy, resulting in sensory abnormalities and …